There has been so much sadness lately. I'm posting this photo to remind me of how much love is still in the world. Being his Momma is my most important job.
🧠 Unlock how the “dark genome” shapes the developing brain. Join our webinar next Thursday (hosted by @Xtalks) to see how Evf2, the first enhancer‑associated lncRNA, is rewriting what is known about genome architecture, interneuron development and neurodevelopmental disease risk.
📅 Save your spot: https://t.co/LtYtBrB2Gs
#3DGenomics #singlecell #Neuro
We’re looking forward to connecting with HCPs at #ACAAI25 this weekend. Many #BlueCrew members will be on-site to meet with clinicians who treat patients with SM and other mast cell disorders every day, helping to strengthen our understanding of these complex diseases.
A mother embraced a pioneering hair test for her son, providing crucial clarity amid delays in autism evaluation, reflecting on the power of innovation. https://t.co/SLlIWKvcR8
The Washington Post recently covered the national conversation around large-scale autism research initiatives. LinusBio's CEO, Dr. Manish Arora, was invited to contribute his perspective.
Read the full story ➡️ https://t.co/HnL5OYPMoW
🍷 HIMSS is better with wine! Join IMO Health for a wine reception at #HIMSS25 from 3:30PM-5:30PM at booth #5032.
✅ Sip fine wines
✅ Connect with health tech leaders
✅ Unwind after a day of innovation
Reserve your glass of wine here: https://t.co/B8LGZW8FW7
#HIMSS2025
We’re extremely proud to announce the launch of ClearStrand-ASD –a ground-breaking, first-of-its kind biomarker test that provides biochemical insights about autism as early as one month of age—using just a single strand of hair!
https://t.co/MCkAvEFX8K
🎉 Big news! #TargetRWE is proud to announce our acquisition by Highlander Health, led by industry trailblazers Dr. Amy Abernethy and Dr. Brad Hirsch, aimed to modernize #ClinicalEvidence generation & improve personalized care for patients.
Link 👉 https://t.co/60Rkje08vp
Tasca Therapeutics, an oncology startup, has launched with $52 million in funding, reflecting a new "austerity-driven" financing reality. https://t.co/vWqXu6dXSi